Radioimmunotherapy in colorectal cancer treatment: present and future

Rákkutatás · Colorectal cancer

Colorectal cancer (CRC) is a deadly form of cancer worldwide.

Colorectal cancer (CRC) is a deadly form of cancer worldwide. Patients with locally advanced rectal cancer and metastatic CRC have a poor long‑term prognosis, and rational and effective treatment remains a major challenge. Common treatments include multi‑modal combinations of surgery, radiotherapy, and chemotherapy; however, recurrence and metastasis rates remain high. The combination of radiotherapy and immunotherapy (radioimmunotherapy [RIT]) may offer new solutions to this problem, but its prospects remain uncertain. This review aimed to summarize the current applications of radiotherapy and immunotherapy, elaborate on the underlying mechanisms, and systematically review the preliminary results of RIT‑related clinical trials for CRC. Studies have identified several key predictors of RIT efficacy. Summarily, rational RIT regimens can improve the outcomes of some patients with CRC, but current study designs have limitations. Further studies on RIT should focus on including larger sample sizes and optimizing the combination therapy regimen based on underlying influencing factors.

The authors highlight the high mortality and treatment challenges in colorectal cancer, underscoring the need for innovative therapies such as radioimmunotherapy to improve patient outcomes.

Bizonyítékszint: Állatkísérletes. Állatmodellben vizsgálták.

Eredeti forrás

Kapcsolódó jelek